safety point is chances of bleeding. & efficacy point is platelet aggregation inhibition in patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention.
Beta blocker either increase or decrease efficacy & safety of prasugrel in ACS patients with PCI?
- 9 May 2012 by monikamodi2012
- 28 May 2012
- bleeding disorder, acute coronary syndrome, percutaneous coronary intervention, prasugrel, platelet aggregation inhibition, beta blocker
I am on a beta blocker, it decreases heart rates, helps lower blood pressure, is used in migraine prophylaxis ... won't interfere with the other meds listed. They won't affect any bleeding issues and won't cause the platelets to stick on anything. They have been around a long time and have been researched extensively. Don't worry
- Prasugrel Information for Consumers
- Prasugrel Information for Healthcare Professionals (includes dosage details)
- Side Effects of Prasugrel (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 28 Sep 2011 • 1 answer
Posted 23 Feb 2012 • 2 answers
Posted 20 Jun 2012 • 1 answer
Posted 22 Aug 2013 • 1 answer
Posted 16 Oct 2017 • 0 answers